In total, our results reveal ArcGABA non-LepR neurons as an alternative neural basis for leptin resistance and effective therapeutic target against obesity and suggest that improving cellular leptin resistance alone may not be able to reduce DIO. This evidence concerns the gene LEPR and obesity disorder.